ELDN - CIK 0001404281
Eledon Pharmaceuticals, Inc. has filed 604 documents with the SEC between 2007 and 2026. The most frequent type is insider trade (165 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2020-11-20 | 2020-11-20 |
| Major company event (amended) | 8-K/A | 2020-11-20 | 2020-09-09 |
| Proxy statement | DEF 14A | 2020-11-20 | 2020-12-18 |
| Activist ownership stake (update) | SC 13D/A | 2020-11-20 | - |
| SEC correspondence | UPLOAD | 2020-11-20 | - |
| Quarterly report | 10-Q | 2020-11-16 | 2020-09-30 |
| Company correspondence | CORRESP | 2020-11-13 | - |
| PRER14A | - | 2020-11-13 | - |
| Passive ownership stake | SC 13G | 2020-11-09 | - |
| SEC correspondence | UPLOAD | 2020-11-09 | - |
| Insider trade | 4 | 2020-11-06 | 2020-10-30 |
| New insider ownership | 3 | 2020-11-06 | 2020-10-30 |
| PRE 14A | - | 2020-10-23 | 2020-10-23 |
| Activist ownership stake (update) | SC 13D/A | 2020-10-14 | - |
| Major company event | 8-K | 2020-10-06 | 2020-10-05 |
| New insider ownership | 3 | 2020-10-05 | 2020-10-01 |
| Passive ownership stake (update) | SC 13G/A | 2020-10-05 | - |
| D | - | 2020-09-25 | - |
| New insider ownership | 3 | 2020-09-24 | 2020-09-14 |
| New insider ownership | 3 | 2020-09-24 | 2020-09-14 |
| 424B3 | - | 2020-09-15 | - |
| Major company event | 8-K | 2020-09-15 | 2020-09-09 |
| Insider trade | 4 | 2020-09-15 | 2020-09-11 |
| Insider trade | 4 | 2020-09-15 | 2020-09-11 |
| Insider trade | 4 | 2020-09-15 | 2020-09-11 |
| Insider trade | 4 | 2020-09-15 | 2020-09-11 |
| Insider trade | 4 | 2020-09-15 | 2020-09-11 |
| New insider ownership | 3 | 2020-09-15 | 2020-09-09 |
| Major company event | 8-K | 2020-09-04 | 2020-09-03 |
| Activist ownership stake (update) | SC 13D/A | 2020-08-18 | - |
| Quarterly report | 10-Q | 2020-08-14 | 2020-06-30 |
| Major company event | 8-K | 2020-06-17 | 2020-06-11 |
| Major company event | 8-K | 2020-05-15 | 2020-05-15 |
| Quarterly report | 10-Q | 2020-05-15 | 2020-03-31 |
| Major company event | 8-K | 2020-05-13 | 2020-05-12 |
| Major company event | 8-K | 2020-04-23 | 2020-04-21 |
| EFFECT | - | 2020-04-03 | - |
| Company correspondence | CORRESP | 2020-04-02 | - |
| Proxy materials | DEFA14A | 2020-03-31 | - |
| Proxy statement | DEF 14A | 2020-03-31 | 2020-05-12 |
| SEC correspondence | UPLOAD | 2020-03-31 | - |
| Employee stock plan | S-8 | 2020-03-25 | - |
| IPO registration | S-1 | 2020-03-25 | - |
| Insider trade | 4 | 2020-03-20 | 2020-03-19 |
| Insider trade | 4 | 2020-03-20 | 2020-03-19 |
| Insider trade | 4 | 2020-03-20 | 2020-03-19 |
| Major company event | 8-K | 2020-03-17 | 2020-03-17 |
| Annual report | 10-K | 2020-03-17 | 2019-12-31 |
| PRE 14A | - | 2020-03-16 | 2020-05-12 |
| Insider trade | 4 | 2020-02-25 | 2020-01-14 |